A placebo-controlled, randomized, double-blind trial to investigate the impact of dapagliflozin on the development of diabetic ketoacidosis and intermediate metabolism in type 1 diabetes using a dual stable tracer method: A safety study investigating the fuel shift theory in the human model - AZ02_Dapa_T1D
Latest Information Update: 30 Jul 2020
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms AZ02_Dapa_T1D
- 30 Jul 2020 New trial record